Publication Listing for the MeSH term cancer therapy. Found 7 abstracts

Wang J, Lai B, Nanayakkara G, Yang Q, Sun Y, Lu Y, Shao Y, Yu D, Yang WY, Cueto R, Fu H, Zeng H, Shen W, Wu S, Zhang C, Liu Y, Choi ET, Wang H, Yang X. Experimental Data-Mining Analyses Reveal New Roles of Low-Intensity Ultrasound in Differentiating Cell Death Regulatome in Cancer and Non-cancer Cells via Potential Modulation of Chromatin Long-Range Interactions. Frontiers in oncology. 2019 Jan;9:600.   PMCID: PMC6640725

Caruso LB, Martin KA, Lauretti E, Hulse M, Siciliano M, Lupey-Green LN, Abraham A, Skorski T, Tempera I. Poly(ADP-ribose) Polymerase 1, PARP1, modifies EZH2 and inhibits EZH2 histone methyltransferase activity after DNA damage. Oncotarget. 2018 Feb 13;9(12):10585-605.   PMCID: PMC5828221

Lu W, Liu Y, Ma H, Zheng J, Tian S, Sun Z, Luo L, Li J, Zhang H, Yang ZJ, Zhang X. Design, Synthesis, and Structure-Activity Relationship of Tetrahydropyrido[4,3-d]pyrimidine Derivatives as Potent Smoothened Antagonists with in Vivo Activity. ACS chemical neuroscience. 2017 Sep 20;8(9):1980-94.

Wagner J, Kline CL, Ralff MD, Lev A, Lulla A, Zhou L, Olson GL, Nallaganchu BR, Benes CH, Allen JE, Prabhu VV, Stogniew M, Oster W, El-Deiry WS. Preclinical evaluation of the imipridone family, analogues of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212. Cell cycle (Georgetown, Tex). 2017 Oct 02;16(19):1790-9.   PMCID: PMC5628644

Meng MB, Wang HH, Cui YL, Wu ZQ, Shi YY, Zaorsky NG, Deng L, Yuan ZY, Lu Y, Wang P. Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy. Oncotarget. 2016 Aug 30;7(35):57391-413.   PMCID: PMC5302997

Chen ML, Xu PZ, Peng XD, Chen WS, Guzman G, Yang XM, Di Cristofano A, Pandolfi PP, Hay N. The deficiency of Akt1 is sufficient to suppress tumor development in Pten(+/-) mice. Genes & development. 2006 Jun;20(12):1569-74.

Brando C, Mukhopadhyay S, Kovacs E, Medina R, Patel P, Catina TL, Campbell KS, Santoli D. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104. Journal of Leukocyte Biology. 2005 Aug;78(2):359-71.

The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

cancer therapy intestinal polyps regulatory receptors ultrasound cytotoxic mechanisins phosphoinositide 3-kinase surface-molecule activating receptors endometrium carcinoma natural cytotoxicity PIN akt molecular-mechanisms Onc206 Onc201 hedgehog signaling pathway tumorigenesis Onc212 relevance cancer anti-tumor immune Atf4 antagonist genetically-engineered mice Genetics & Heredity scaffold hopping thyroid and adrenal tumors cell death regulators necroptosis with the contents of this article pkb Parp1 mutation in-vivo cytotoxic lymphocytes therapy inflammatory pathways Gpcr neoplasia Dr5 medulloblastoma synthetic lethality pten immunodeficient scid mice Smoothened pathway target-cells Trail Developmental Biology hla-a Chop Ezh2 imipridone chromatin long-range interaction DNA damage